Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia.

Christian JB, Arondekar B, Buysman EK, Johnson SL, Seeger JD, Jacobson TA.

J Clin Lipidol. 2012 Sep-Oct;6(5):450-61. doi: 10.1016/j.jacl.2012.08.007.

PMID:
23009781
2.

Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia.

Christian JB, Arondekar B, Buysman EK, Jacobson TA, Snipes RG, Horwitz RI.

Am J Med. 2014 Jan;127(1):36-44.e1. doi: 10.1016/j.amjmed.2013.09.018.

PMID:
24384100
3.

Clinical and economic outcomes in a real-world population of patients with elevated triglyceride levels.

Toth PP, Grabner M, Ramey N, Higuchi K.

Atherosclerosis. 2014 Dec;237(2):790-7. doi: 10.1016/j.atherosclerosis.2014.09.029.

4.

Hospital use and medical care costs up to 5 years after triglyceride lowering among patients with severe hypertriglyceridemia.

Nichols GA, Arondekar B, Jacobson TA.

J Clin Lipidol. 2012 Sep-Oct;6(5):443-9. doi: 10.1016/j.jacl.2012.03.002.

PMID:
23009780
5.

Patient characteristics and medical care costs associated with hypertriglyceridemia.

Nichols GA, Arondekar B, Garrison LP Jr.

Am J Cardiol. 2011 Jan 15;107(2):225-9. doi: 10.1016/j.amjcard.2010.09.010.

PMID:
21211599
6.

Changes in triglyceride levels over time and risk of type 2 diabetes in young men.

Tirosh A, Shai I, Bitzur R, Kochba I, Tekes-Manova D, Israeli E, Shochat T, Rudich A.

Diabetes Care. 2008 Oct;31(10):2032-7. doi: 10.2337/dc08-0825.

7.

Incidence of acute pancreatitis in human immunodeficiency virus-positive patients with hypertriglyceridemia: is it really high?

Sun HY, Chang SY, Sheng WH, Chen MY, Hsieh SM, Tseng YT, Lu CL, Yang CJ, Wu H, Liu WC, Wu CH, Hung CC, Chang SC.

Pancreas. 2012 Mar;41(2):283-9. doi: 10.1097/MPA.0b013e3182267fc0.

PMID:
22343978
8.

Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease.

Eberly LE, Stamler J, Neaton JD; Multiple Risk Factor Intervention Trial Research Group..

Arch Intern Med. 2003 May 12;163(9):1077-83.

PMID:
12742806
10.

Decrease in triglyceride level by bezafibrate is related to reduction of recurrent coronary events: a Bezafibrate Infarction Prevention substudy.

Haim M, Benderly M, Boyko V, Goldenberg I, Tanne D, Battler A, Goldbourt U, Behar S; Bezafibrate Infarction Prevention (BIP) Study Group..

Coron Artery Dis. 2006 Aug;17(5):455-61.

PMID:
16845254
11.

Triglyceride levels and apolipoprotein E polymorphism in patients with acute pancreatitis.

Ivanova R, Puerta S, Garrido A, Cueto I, Ferro A, Ariza MJ, Cobos A, Gonzalez-Santos P, Valdivielso P.

Hepatobiliary Pancreat Dis Int. 2012 Feb;11(1):96-101.

12.

The combined effect of pre-transplant triglyceride levels and the type of calcineurin inhibitor in predicting the risk of new onset diabetes after renal transplantation.

Porrini E, Delgado P, Alvarez A, Cobo M, Pérez L, González-Posada JM, Hortal L, Gallego R, García JJ, Checa M, Morales A, Salido E, Hernández D, Torres A.

Nephrol Dial Transplant. 2008 Apr;23(4):1436-41.

13.

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women.

Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM.

JAMA. 2007 Jul 18;298(3):309-16.

PMID:
17635891
14.

Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis.

Sprecher DL, Pearce GL, Park EM, Pashkow FJ, Hoogwerf BJ.

Diabetes Care. 2000 Nov;23(11):1648-53.

15.

[Hyperlipemic pancreatitis: clinical course].

Chebli JM, de Souza AF, de Paulo GA, Pace FH, Alves RA, Froede EC, Meirelles GS, do Carmo LA, Ribeiro TC, Ribeiro AM, Lopes MH, Ferreira LE, Gaburri PD.

Arq Gastroenterol. 1999 Jan-Mar;36(1):4-9. Portuguese.

PMID:
10511873
16.

Nonfasting triglycerides and risk of ischemic stroke in the general population.

Freiberg JJ, Tybjaerg-Hansen A, Jensen JS, Nordestgaard BG.

JAMA. 2008 Nov 12;300(18):2142-52. doi: 10.1001/jama.2008.621.

PMID:
19001625
17.

Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial.

Arbel Y, Klempfner R, Erez A, Goldenberg I, Benzekry S, Shlomo N, Fisman EZ, Tenenbaum A; BIP Study Group..

Cardiovasc Diabetol. 2016 Jan 22;15:11. doi: 10.1186/s12933-016-0332-6.

18.

Emergent therapy with therapeutic plasma exchange in acute recurrent pancreatitis due to severe hypertriglyceridemia.

Kadikoylu G, Yukselen V, Yavasoglu I, Coşkun A, Karaoglu AO, Bolaman Z.

Transfus Apher Sci. 2010 Dec;43(3):285-9. doi: 10.1016/j.transci.2010.09.009.

PMID:
20926345
19.

Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model.

Shinozaki T, Matsuyama Y, Iimuro S, Umegaki H, Sakurai T, Araki A, Ohashi Y, Ito H; Japanese Elderly Diabetes Intervention Trial Research Group..

Geriatr Gerontol Int. 2012 Apr;12 Suppl 1:88-102. doi: 10.1111/j.1447-0594.2011.00816.x.

PMID:
22435944
20.

[Acute pancreatitis caused by hypertriglyceridemia].

Baranyai T, Terzin V, Vajda A, Wittmann T, Czakó L.

Orv Hetil. 2010 Nov 7;151(45):1869-74. doi: 10.1556/OH.2010.28966. Hungarian.

PMID:
20980226
Items per page

Supplemental Content

Support Center